BPCIA 180-Day Notice of Intent to Market a Biosimilar Is Required, Enforceable by Injunction
By EsqSocial Corporation 01/09/16
In an opinion that details many intricacies of both the Biologics Price Competition and Innovation Act of 2009 (BPCIA) and related portions of the Patent Act, the US Court of Appeals for the Federal Circuit affirmed a district court’s grant of a...
By: McDermott Will & Emery